218 related articles for article (PubMed ID: 20549546)
1. Expression of Oct4 in HCC and modulation to wnt/β-catenin and TGF-β signal pathways.
Yuan F; Zhou W; Zou C; Zhang Z; Hu H; Dai Z; Zhang Y
Mol Cell Biochem; 2010 Oct; 343(1-2):155-62. PubMed ID: 20549546
[TBL] [Abstract][Full Text] [Related]
2. GATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genes.
Feng H; Zhu M; Zhang R; Wang Q; Li W; Dong X; Chen Y; Lu Y; Liu K; Lin B; Guo J; Li M
J Cell Mol Med; 2019 Apr; 23(4):2536-2548. PubMed ID: 30672133
[TBL] [Abstract][Full Text] [Related]
3. [Analysis on the expression of the stem cells related genes in hepatocellular carcinoma cell lines].
Zou C; Yuan FJ; Zhou WB; Huang L; Wang J; Zhang YS
Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):599-602. PubMed ID: 19719918
[TBL] [Abstract][Full Text] [Related]
4. Opposing effects of Tcf3 and Tcf1 control Wnt stimulation of embryonic stem cell self-renewal.
Yi F; Pereira L; Hoffman JA; Shy BR; Yuen CM; Liu DR; Merrill BJ
Nat Cell Biol; 2011 Jun; 13(7):762-70. PubMed ID: 21685894
[TBL] [Abstract][Full Text] [Related]
5. UNC119 promoted cell growth and migration by Wnt/β-catenin signal and TGF-β/EMT signal pathway in hepatocellular carcinoma.
Liu ZH; Zhang YF; Xu ZD; Z H L; Y F Z; Z D X
J BUON; 2018; 23(6):1717-1724. PubMed ID: 30610799
[TBL] [Abstract][Full Text] [Related]
6. Interferon-α2b and transforming growth factor-β1 treatments on HCC cell lines: Are Wnt/β-catenin pathway and Smads signaling connected in hepatocellular carcinoma?
Ceballos MP; Parody JP; Alvarez Mde L; Ingaramo PI; Carnovale CE; Carrillo MC
Biochem Pharmacol; 2011 Dec; 82(11):1682-91. PubMed ID: 21843516
[TBL] [Abstract][Full Text] [Related]
7. Dual roles of Oct4 in the maintenance of mouse P19 embryonal carcinoma cells: as negative regulator of Wnt/β-catenin signaling and competence provider for Brachyury induction.
Marikawa Y; Tamashiro DA; Fujita TC; Alarcon VB
Stem Cells Dev; 2011 Apr; 20(4):621-33. PubMed ID: 21083502
[TBL] [Abstract][Full Text] [Related]
8. UNC119 promotes the growth and migration of hepatocellular carcinoma via Wnt/β/catenin and TGF/β-EMT signaling pathways.
Liu Z; Zhang Y; Xu Z
J BUON; 2018; 23(1):188-192. PubMed ID: 29552782
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of TGF-β/Smad signaling dependent cytostasis in human hepatocellular carcinoma cell lines.
Dzieran J; Fabian J; Feng T; Coulouarn C; Ilkavets I; Kyselova A; Breuhahn K; Dooley S; Meindl-Beinker NM
PLoS One; 2013; 8(8):e72252. PubMed ID: 23991075
[TBL] [Abstract][Full Text] [Related]
10. βII-Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin.
Zhi X; Lin L; Yang S; Bhuvaneshwar K; Wang H; Gusev Y; Lee MH; Kallakury B; Shivapurkar N; Cahn K; Tian X; Marshall JL; Byers SW; He AR
Hepatology; 2015 Feb; 61(2):598-612. PubMed ID: 25307947
[TBL] [Abstract][Full Text] [Related]
11. Krüppel-like factor 8 is a new Wnt/beta-catenin signaling target gene and regulator in hepatocellular carcinoma.
Yang T; Cai SY; Zhang J; Lu JH; Lin C; Zhai J; Wu MC; Shen F
PLoS One; 2012; 7(6):e39668. PubMed ID: 22761862
[TBL] [Abstract][Full Text] [Related]
12. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
13. UNC119 promotes the growth and migration of hepatocellular carcinoma via Wnt/β-catenin and TGF-β/EMT signaling pathways.
Liu Z; Zhang Y; Xu Z
J BUON; 2018; 23(1):185-187. PubMed ID: 29552781
[TBL] [Abstract][Full Text] [Related]
14. [The role and significance of Wnt/beta-catenin signaling pathway regulating the signaling molecules in hepatocellular carcinoma].
Wang XH; Sun X; Meng XW; Lü ZW; Liu MN; Pei FH
Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):672-5. PubMed ID: 20943078
[TBL] [Abstract][Full Text] [Related]
15. SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway.
Shih YL; Hsieh CB; Lai HC; Yan MD; Hsieh TY; Chao YC; Lin YW
Int J Cancer; 2007 Sep; 121(5):1028-35. PubMed ID: 17443492
[TBL] [Abstract][Full Text] [Related]
16. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways.
Lei S; Dubeykovskiy A; Chakladar A; Wojtukiewicz L; Wang TC
J Biol Chem; 2004 Oct; 279(41):42492-502. PubMed ID: 15292219
[TBL] [Abstract][Full Text] [Related]
17. beta-catenin siRNA regulation of apoptosis- and angiogenesis-related gene expression in hepatocellular carcinoma cells: potential uses for gene therapy.
Wang XH; Sun X; Meng XW; Lv ZW; Du YJ; Zhu Y; Chen J; Kong DX; Jin SZ
Oncol Rep; 2010 Oct; 24(4):1093-9. PubMed ID: 20811694
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
[TBL] [Abstract][Full Text] [Related]
19. Cyr61/CCN1 is regulated by Wnt/β-catenin signaling and plays an important role in the progression of hepatocellular carcinoma.
Li ZQ; Ding W; Sun SJ; Li J; Pan J; Zhao C; Wu WR; Si WK
PLoS One; 2012; 7(4):e35754. PubMed ID: 22540002
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of OCT4 contributes to progression of hepatocellular carcinoma.
Xu G; Qi F; Zhang J; Xu J; Shi T; Miao Y
Tumour Biol; 2016 Apr; 37(4):4649-54. PubMed ID: 26508029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
